Terri Kueber, CRNA, MS. Explain the pathophysiology and classification of Myasthenia Gravis (MG) List the signs and symptoms and clinical manifestation.

Slides:



Advertisements
Similar presentations
Neurological Diseases Jerry Carley RN, MSN, MA, CNE
Advertisements

FACULTY OF MEDICINE PHYSIOLOGY DEPARTMENT DR. NERMEN MADY DR. RAMEZ.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 15 Cholinesterase Inhibitors and Their Use in Myasthenia Gravis.
Myasthenia Gravis Dr. Belal M. Hijji, RN. PhD February 29, 2012.
Muscle weakness Index case Year 1 Michaelmas Term.
Guillain-Barré Syndrome, Myasthenia Gravis,
37 yo F Engineer PC: Double vision, fatigue, difficulty swallowing. HPC: - 3/52 of worsening diplopia, worse in afternoons - 3/7 of intermittent weakness.
Muscle Disorders and General Anaesthetics Ben Creagh-Brown, UHL May 2004.
Nuha Alkhawajah MD.   Disorders affecting the junction between the presynaptic nerve terminal and the postsynaptic muscle membrane  Pure motor syndromes.
Agents Used to Treat Musculoskeletal Health Alterations.
Therapeutic Plasma Exchange for Myasthenia Gravis Clifford Blieden, MD Houston Methodist Hospital Department of Pathology and Genomic Medicine, Division.
 Myasthenia gravis is a chronic autoimmune neuromuscular disease that is characterized by different degrees of weakness of the skeletal muscles of the.
Ocular Myasthenia Gravis: Past, Present, and Future
1 Review of Musculoskeletal System Chapter Muscle Skeletal muscle > 600 muscles in body Fascia –Epimysium – forms tendons at ends –Perimysium –
Myasthenia Gravis Blaine Suing November 21 st 2007.
Anaesthesia in myasthenia Dr. S. Parthasarathy MD., DA., DNB, MD (Acu), Dip. Diab. DCA, Dip. Software statistics, PhD (physio) Mahatma Gandhi Medical college.
GENERAL THORACIC SURGERY CHAPTER 168
Difficult Weaning. Indications for mechanical ventilation: A) Global pathophysiological indications: - Apnea - Acute ventilatory failure - impending failure.
Public Health – Dresden Medical School Complementary care seeking behavior in patients with Myasthenia gravis J. Klewer 1, L. Wondzinski 1, A. Friedrich.
Guillain-Barré Syndrome Miss Fatima Hirzallah Guillain-Barré syndrome is an autoimmune attack on the peripheral nerve myelin. The result is acute, rapid.
Myasthenia Gravis.  Describe myasthenia gravis  Signs and Symptoms of the disease  Describe the treatments available Purpose and Objectives.
Disorders of neuromuscular junction: Prepared by: Dr. Sarwer Jamal Bajalan M.B.Ch.B, F.I.B.M.S(Neurology)
MYASTHENIA GRAVIS (MG)
Sophia M. Chung, M.D. Depts of Ophthalmology &
This lecture was conducted during the Nephrology Unit Grand Ground by Medical Student rotated under Nephrology Division under the supervision and administration.
A 64 y/o Woman with Dyspnea Pamela Ryan MD February 14, 2007.
Myasthenia Gravis Victor Politi,M.D.
MYASTHENIA GRAVIS ANESTHESIOLOGY Jasdeep Dhaliwal Clinical Rotation.
Pathophysiology, Diagnosis and Medical Management of Myasthenia Gravis
Linda S. Williams / Paula D. Hopper Copyright © F.A. Davis Company Understanding Medical Surgical Nursing, 4th Edition Chapter 50 Nursing Care of.
AIM OF THIS PRESENTATION  Introduce the important components of the Autoimmune Diseases.  Demonstrate what happens when things go wrong & the body turns.
Childhood Myasthenia Gravis (MG) Roula al-Dahhak, M.D. Assistant Professor of Pediatrics and Neurology Columbus Children’s Research Institute Neuromuscular.
Department of Neurology, The 2nd affiliated hospital, kunming Medical College Yinfengqiong.
Myasthenia Gravis.
Hypothyroidism Group A
Neuromuscular Signs and Symptoms: Muscle stiffness, ptosis, axial muscle weakness 1 W. David Arnold, MD AAPMR 2015 Disclosure: I receive funding through.
Disorders of the Neuromuscular Junction
Myasthenia Gravis.
Neurology Chapter of IAP
NEUROPATHY Subsection B3 Francisco – Go, Kerby + Laxamana September 16, 2009.
MYASTHENIA GRAVIS Aswad H. Al.Obeidy FICMS, FICMS GE&Hep Kirkuk General Hospital.
F.Ahmadabadi MD Child Neurologist July 2015 ARUMS Guillain-Barre syndrome & Myasthenia Gravis.
MYASTHENIA GRAVIS “FROM WEAKNESS SHALL COME STRENGTH”. BY PATTI HAMILTON.
Assessment and Treatments  History: weakness caused by any precipitating factors ( i.e. infection, emotional upset)  Time of weakness: after repeated.
Copyright © 2006 by Mosby, Inc. Slide 1 Chapter 30 Myasthenia Gravis Figure Myasthenia gravis. Inset, Atelectasis, a common secondary anatomic alteration.
Autonomic Nervous System (ANS) Cholinergic Drugs 4 أ0م0د.وحدة بشير اليوزبكي.
Nursing management of Myasthenia Gravis
Outcome of Thymectomy in Juvenile Myasthenia Gravis
Myaesthenia Gravis in Pregnancy. Dr. Mridula A. Benjamin Dept of Obs and Gyn, RIPAS Hospital, Brunei.
Myasthenia Gravis.
Myasthenia Gravis.
Nursing Care of Patients with Peripheral Nervous System Disorders.
Understanding Medical Surgical Nursing, 4th Edition CHAPTER 50 Nursing Care of Patients with Peripheral Nervous System Disorders.
Jennifer Vilarino Period: 5
Neuromuscular disorders
Guillain-Barre Syndrome
Myasthenia Gravis.
Neuromuscular junction
Muscular Disorders and Diseases
Multisystem.
a presentation on auto-immune disorders
Manage a Neurological Mystery
Myasthenia Gravis Johan Perrand Period 3.
Myasthenia Gravis.
Muscle Disorders and General Anaesthetics
Post-operative Pain Management
Myasthenia gravis By: Nikki Young.
“Grave Muscle Weakness”
Chapter 6 Muscarinic [,mʌskə‘rinik]毒蕈碱的 receptor agonists
Presentation transcript:

Terri Kueber, CRNA, MS

Explain the pathophysiology and classification of Myasthenia Gravis (MG) List the signs and symptoms and clinical manifestation Describe the various treatments available for Myasthenia Gravis Discuss the anesthetic considerations for patients with Myasthenia Gravis

Myasthenia Gravis is an autoimmune neuromuscular Consider a “Snowflake Disease” Cause is still unknown No known cure History Incident and prevalence is increasing with 5-10 per 100,000  25,000 cases in US Still considered sporadic Women versus men Often associated with other autoimmune disorders

Class I: Ocular weakness, other muscle are normal Class II: Mild weakness affecting other muscle Class IIa: Muscles weakness affecting limbs and possibly oropharyngeal muscles Class III: Moderate weakness/severe ocular weakness Class IV: Severe weakness affecting limb muscle Class V: Defined by intubation

Ocular Myasthenia Gravis Classic General Myasthenia Gravis Transient Neonatal Myasthenia Gravis Juvenile Myasthenia Gravis Congenital Types Drug-induced (Pencillamine, NDMR, aminoglycosides, procainamide)

Bilateral or Unilateral Ptosis Diplopia Hoarseness Altered Speech Problems chewing Dysphagia Limited Facial Expressions

Endrophonium (tensilon) Chloride Test mg initial dose Neostigmine may be used in patients who do not respond to tensilon Auto-antibodies in MG – receptor binding antibodies are present in 80% of patients Thymic hyperplasia is present in 70%

Electromyography (EMG) Testing Repetitive Nerve Stimulation (RNS) Single Fiber EMG (SFEMG) Ocular Cooling Other Testing

Congenital Myasthenia Syndromes (not autoimmune) Drug induced MG Eaton-Lambert Syndrome (related to Small cell carcinoma of the lung) Hyperthyroidism (increases MG symptoms) Graves disease Botulism Ophthalmoplegia Intracranial pathology

Fatigue or insufficient sleep Stress, anxiety, illness Overexertion, repetitive motion Pain or depression Low potassium or thyroid levels Alcoholic beverages Sudden fear, or extreme anger Extreme temperatures Humidity Sunlight or bright lights Hot foods or beverages Medications (beta blockers, antibiotics, calcium blockers) Chemicals such as household cleaner, insecticides, pet sprays, lawn chemicals

Cholinesterase inhibitor Pyridostigmine – most commonly used Neostigmine – used less frequently Thymectomy Plasmapheresis Corticoid Steroid Therapy Immunosuppressive therapy (azathioprine, cyclosporine, etc.) Short-term Immunotherapy (IV immunoglobulin)

Current health and symptoms PMH/PSH NMBA – Monitoring Post operative plan Pain control Induction and Extubation criteria

46 year old male diagnosis with MG in 6/2006 Presenting symptoms: fatigue and weakness after working out with intermittent dipoplia At time of diagnosis weakness lead to respiratory failure leading ventilation and respiratory support x 3 days Residual symptoms: weakness, pain and left ptosis Refractory to medical support under went a thymectomy in October 2009

Height/Weight: 75”/95=4.7 PFT’s FVC=65%, FEV1/FVC=61% Did not take his Pyridostigmine this am as he was instructed not to take it (not by anesthesia department)

Gave Pyridostigmine 90 mg preoperatively IV Additional dose give at 1400 in recovery room Induction included: slow induction no neuromuscular blocking agents Total Agents included: Propofol 400mg Fentanyl 300 Morphine 4mg Midazolam 3 mg Intubation with glidescope secondary to NIM’s tube placement.

Successfully extubated at end of case Received pyridostigmine in recovery room ICU overnight Discharge next day.

63 year old male Diagnosis between 12/05 and 2/06 Schedule for Laparoscopic Nissen Fundoplication Multiple drug allergies Ex-smoker (2 PPD x 30 years) H/O: MG controlled with medications, HTN, diet controlled, AST – normal with EF 55-65% Hiatal Hernia/Barrett’s Esophagus Previous surgery included: Brow lift, Laparoscopic Cholecystectomy

Previous anesthetic records Surgeons desire muscle relaxation We did: Propofol 350mg Fentanyl 400 mcg Midazolam 2 mg Zofran/Decadron Ephedrine 15mg Vasopressin 2 units Patient’s was successfully extubated in OR and discharge home the next day

Questions??